Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Journal of Korean Medical Science ; : 405-417, 2010.
Artigo em Inglês | WPRIM | ID: wpr-161038

RESUMO

Recent evidence suggests that gastric mucosal injury induces adaptive changes in DNA methylation. In this study, the methylation status of the key tissue-specific genes in normal gastric mucosa of healthy individuals and cancer patients was evaluated. The methylation-variable sites of 14 genes, including ulcer-healing genes (TFF1, TFF2, CDH1, and PPARG), were chosen from the CpG-island margins or non-island CpGs near the transcription start sites. The healthy individuals as well as the normal gastric mucosa of 23 ulcer, 21 non-invasive cancer, and 53 cancer patients were examined by semiquantitative methylation-specific polymerase chain reaction (PCR) analysis. The ulcer-healing genes were concurrently methylated with other genes depending on the presence or absence of CpG-islands in the normal mucosa of healthy individuals. Both the TFF2 and PPARG genes were frequently undermethylated in ulcer patients. The over- or intermediate-methylated TFF2 and undermethylated PPARG genes was more common in stage-1 cancer patients (71%) than in healthy individuals (10%; odds ratio [OR], 21.9) and non-invasive cancer patients (21%; OR, 8.9). The TFF2-PPARG methylation pattern of cancer patients was stronger in the older-age group (> or =55 yr; OR, 43.6). These results suggest that the combined methylation pattern of ulcer-healing genes serves as a sensitive marker for predicting cancer-prone gastric mucosa.


Assuntos
Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Biomarcadores/metabolismo , Caderinas/genética , Ilhas de CpG , Metilação de DNA , Mucosa Gástrica/patologia , Regulação Neoplásica da Expressão Gênica , Substâncias de Crescimento/genética , Invasividade Neoplásica , PPAR gama/genética , Peptídeos/genética , Neoplasias Gástricas/genética , Úlcera Gástrica/genética , Proteínas Supressoras de Tumor/genética , Cicatrização/genética
2.
Arq. bras. endocrinol. metab ; 49(5): 797-804, out. 2005.
Artigo em Português | LILACS | ID: lil-419982

RESUMO

O câncer de próstata (CP) é uma das principais causas de doença e morte, representando no Brasil a segunda causa de óbitos por câncer em homens. A hiperplasia prostática benigna (HPB) é uma doença progressiva de alta prevalência, com evidências histológicas em 50 por cento dos homens aos 50 anos e 90 por cento aos 80 anos de idade. A patogênese das neoplasias prostáticas tem sido associada à ação dos androgênios e a seu receptor nuclear específico, embora os mecanismos moleculares que envolvem os processos de proliferação, diferenciação e apoptose não estejam bem estabelecidos, assim como os mecanismos de transformação neoplásica e carcinogênese. Co-ativadores e co-repressores podem também contribuir para a carcinogênese prostática, ligando-se diretamente aos receptores nucleares, recrutando proteínas adicionais e interagindo com a maquinaria transcricional para aumentar a transcrição de genes-alvo. Polimorfismos do receptor de androgênios e da 5alfa redutase tipo 2 foram identificados e poderiam estar associados com risco para CP. Genes reguladores do ciclo celular e da apoptose, bem como fatores de crescimento, também participam de processos relacionados com a tumorigênese prostática. Assim, alterações no padrão da expressão gênica do tecido normal podem levar ao desenvolvimento do fenótipo maligno e potencialmente estes genes podem servir como marcadores de prognóstico. Com o advento de novas tecnologias moleculares, o número de genes marcadores potenciais para o CP cresce dia a dia, mas os dados atuais requerem ainda validação com maior número de amostras e correlação com o processo da doença. Trazê-los do ambiente de laboratório para o uso clínico requer uma análise rigorosa e há, portanto, um longo caminho ainda a percorrer.


Assuntos
Idoso , Idoso de 80 Anos ou mais , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias da Próstata/genética , Biomarcadores Tumorais/genética , Transformação Celular Neoplásica/genética , Transformação Celular Neoplásica/metabolismo , Progressão da Doença , Regulação Neoplásica da Expressão Gênica/genética , Substâncias de Crescimento/genética , Prognóstico , Polimorfismo Genético/genética , Neoplasias da Próstata/metabolismo , Receptores Androgênicos/genética , Receptores Androgênicos/metabolismo
3.
Journal of Korean Medical Science ; : 480-486, 1999.
Artigo em Inglês | WPRIM | ID: wpr-187372

RESUMO

Chemokine KC has been considered to be a murine homologue of human GRO/MGSA and was identified as chemoattractant for monocytes and neutrophils. This study examined the expression of KC mRNA in thioglycollate-elicited mouse peritoneal macrophages that were stimulated in vitro with Candida albicans (CA). Also examined were the inhibitory effects of IL-10 on the CA-induced expression of KC gene by Northern blot analysis. CA was found to induce chemokine gene expression in a gene-specific manner, CXC chemokine IP-10 mRNA expression was not detected in CA-stimulated macrophages. Maximum KC mRNA expression was observed approximately 2 hr after adding CA. The inhibitory action of IL-10 to CA-induced KC mRNA expression on mouse peritoneal macrophages was independent on concentration and stimulation time of IL-10 and was observed approximately one hour after adding IL-10 and CA simultaneously. IL-10 produced a decrease in the stability of KC mRNA, and CA-stimulated macrophages with cycloheximide blocked the suppressive effect of IL-10. These results suggest that CA also induces chemokine KC from macrophages, and IL-10 acts to destabilize CA-induced KC mRNA and de novo synthesis of an intermediate protein is a part of the IL-10 suppressive mechanism.


Assuntos
Camundongos , Animais , Northern Blotting , Candida albicans/metabolismo , Células Cultivadas , Fatores Quimiotáticos/genética , Dactinomicina/farmacologia , Relação Dose-Resposta a Droga , Regulação da Expressão Gênica/efeitos dos fármacos , Substâncias de Crescimento/genética , Interleucina-10/farmacologia , Interleucina-10/metabolismo , Macrófagos/fisiologia , Camundongos Endogâmicos BALB C , Inibidores da Síntese de Ácido Nucleico/farmacologia , RNA Mensageiro/metabolismo , RNA Mensageiro/efeitos dos fármacos
4.
Medicina (B.Aires) ; 57(Supl.2): 75-80, Aug. 1997.
Artigo em Espanhol | LILACS | ID: lil-320007

RESUMO

The participation of viruses in mammary carcinogenesis has been largely studied in animals. A model similar to the mouse mammary tumor virus (MMTV) was previously proposed. Several lines of research supported the participation of MMTV in human breast cancer, but these evidences were contradicted when further research was performed. One major issue was the presence of human endogenous retroviral sequences that confounded results reporting MMTV-like sequences in human breast cancer. To overcome this problem we selected a 660 bp sequence of the MMTV env gene with low homology to endogenous sequences and search for a sequence to it using the polymerase chain reaction (PCR). The sequence was found in 38 of the human breast cancers and in 2 of the normal breasts studied. The sequence was not present in tumors from other organs. It was 90-98 homologous to MMTV and only 18 to human endogenous retrovirus (HERV) K-10. It was also detected in some of the positive tumors by Southern blot hybridization using one of the cloned 660 bp as a probe. Using reverse transcriptase PCR, it was possible to demonstrate that the 660 bp sequence is expressed in the majority of the tumors. Also, preliminary experiments revealed that sequences related to the LTR and gag genes of MMTV were present in the DNA of breast tumors. The origin of the MMTV-like sequences in tumor DNA could be the result of integrated MMTV-like sequences derived from a human mammary virus or may represent unknown endogenous sequences that can only be detected in breast tumors.


Assuntos
Humanos , Animais , Camundongos , Neoplasias da Mama , Infecções por Retroviridae/genética , Infecções Tumorais por Vírus/genética , Neoplasias Mamárias Experimentais/genética , Vírus do Tumor Mamário do Camundongo/genética , Neoplasias da Mama , Substâncias de Crescimento/genética
5.
Journal of Korean Medical Science ; : 155-163, 1995.
Artigo em Inglês | WPRIM | ID: wpr-7340

RESUMO

This study was performed to prove the hypothesis that oncogene expressions would have the same patterns with those of cellular growth to growth factors in FRTL-5 cells. Ribonucleic acids of FRTL-5 were extracted at 15', 30', 60' and 120' after administration of growth factors to quiescent FRTL-5, and blotted to the nitrocellulose membrane. They were hybridized with radiolabelled c-fos, c-myc and beta-actin probes. Hybridized dot blots were autoradiographed and the amount of radioactivity was measured by densitometry. Densitometric readings were used as the indices of oncogene expressions. Expressions of c-fos and c-myc were more prominent in combined administrations of TSH (10 mU/ml) and IGF-I (100 ng/ml) or IgG of Graves' disease (Graves' IgG; 1 mg/ml) and IGF-I than in combined administration of TSH and Graves' IgG. IgG of primary myxedema suppressed oncogene expressions by TSH or Graves' IgG, but not by IGF-I. From the above results, it was suggested that expressions of c-fos and c-myc to growth factors would have similar patterns with those of cell growth to growth factors in FRTL-5, and the actions of TSH and Graves' IgG would be manifested through same signal transduction system, but IGF-I would be manifested by its own.


Assuntos
Ratos , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular/citologia , Expressão Gênica/efeitos dos fármacos , Doença de Graves/imunologia , Substâncias de Crescimento/genética , Imunoglobulina G/farmacologia , Fator de Crescimento Insulin-Like I/farmacologia , Mixedema/imunologia , Proteínas Proto-Oncogênicas c-fos/genética , Proteínas Proto-Oncogênicas c-myc/genética , RNA/análise , Ratos Endogâmicos F344 , Glândula Tireoide/citologia , Tireotropina/farmacologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA